Kevin J Yeaman's most recent trade in Dolby Laboratories Inc - Ordinary Shares - Class A was a trade of 25,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 25,000 | 85,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 72.31 per share. | 12 Aug 2025 | 25,000 | 114,725 (0%) | 0% | 72.3 | 1,807,828 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 12 Aug 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 74.81 per share. | 15 Jul 2025 | 39,595 | 115,005 (0%) | 0% | 74.8 | 2,962,205 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 15 Jul 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 25,000 | 110,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 14,875 | 37,942 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 15 Jul 2025 | 14,875 | 154,600 (0%) | 0% | 64.6 | 960,925 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 2,491 | 35,451 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 15 Jul 2025 | 2,491 | 114,725 (0%) | 0% | 75 | 186,825 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 15 Jul 2025 | 2,491 | 117,216 (0%) | 0% | 64.6 | 160,919 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 75.30 per share. | 15 Jul 2025 | 280 | 114,725 (0%) | 0% | 75.3 | 21,085 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2025 | 25,000 | 135,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 24 Jun 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 74.02 per share. | 24 Jun 2025 | 25,000 | 114,725 (0%) | 0% | 74.0 | 1,850,530 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 76.22 per share. | 10 Jun 2025 | 33,504 | 114,904 (0%) | 0% | 76.2 | 2,553,775 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 25,000 | 160,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 10 Jun 2025 | 25,000 | 139,725 (0%) | 0% | 45.5 | 1,137,500 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 8,683 | 52,817 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.60 per share. | 10 Jun 2025 | 8,683 | 148,408 (0%) | 0% | 64.6 | 560,922 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 76.57 per share. | 10 Jun 2025 | 179 | 114,725 (0%) | 0% | 76.6 | 13,706 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2025 | 95,671 | 95,671 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2025 | 95,671 | 95,671 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 95,671 | 95,671 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 54,425 | 174,745 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc | Kevin Yeaman J. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.18 per share. | 16 Dec 2024 | 31,483 | 127,735 (0%) | 0% | 79.2 | 2,492,824 | Class A Common Stock |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 27,212 | 27,212 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 15,477 | 182,543 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc | Yeaman Kevin J. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 15,477 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc | Yeaman Kevin J. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 25 Oct 2024 | 50,000 | 133,721 (0%) | 0% | 62.3 | 3,116,000 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 50,000 | 7,888 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 80.53 per share. | 25 Oct 2024 | 49,104 | 84,617 (0%) | 0% | 80.5 | 3,954,232 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.32 per share. | 25 Oct 2024 | 7,888 | 91,609 (0%) | 0% | 62.3 | 491,580 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2024 | 7,888 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Yeaman J. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 80.19 per share. | 25 Oct 2024 | 7,888 | 83,721 (0%) | 0% | 80.2 | 632,539 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin Yeaman J. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.18 per share. | 25 Oct 2024 | 896 | 83,721 (0%) | 0% | 81.2 | 72,734 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 100.00 per share. | 17 Jun 2024 | 2 | 2 (0%) | 0% | 100 | 200 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 81,884 | 81,884 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Yeaman J. Kevin | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Feb 2024 | 81,884 | 81,884 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Yeaman J. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.51 per share. | 17 Jan 2024 | 9,030 | 83,721 (0%) | 0% | 83.5 | 754,083 | Class A Common Stock |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 8,784 | 185,615 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 17 Jan 2024 | 8,784 | 92,751 (0%) | 0% | 45.5 | 399,672 | Class A Common Stock |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 17 Jan 2024 | 246 | 83,967 (0%) | 0% | 43.0 | 10,573 | Class A Common Stock |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 246 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Yeaman J. Kevin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 81,884 | 81,884 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 46,718 | 166,275 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.60 per share. | 15 Dec 2023 | 26,047 | 130,945 (0%) | 0% | 88.6 | 2,307,764 | Class A Common Stock |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 23,359 | 23,359 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc | J. Yeaman Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 17,202 | 174,804 (0%) | 0% | - | Class A Common Stock | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 17,202 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc | Yeaman Kevin J. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.49 per share. | 15 Dec 2023 | 5,268 | 120,320 (0%) | 0% | 87.5 | 460,897 | Class A Common Stock |
| Dolby Laboratories Inc | Yeaman J. Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 18,060 | 246 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | J. Kevin Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 12 Dec 2023 | 18,060 | 69,939 (0%) | 0% | 43.0 | 776,219 | Class A Common Stock |
| Dolby Laboratories Inc | Yeaman J. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 89.17 per share. | 12 Dec 2023 | 18,060 | 51,879 (0%) | 0% | 89.2 | 1,610,435 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2023 | 45,150 | 18,306 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 21 Nov 2023 | 45,150 | 97,029 (0%) | 0% | 43.0 | 1,940,547 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 21 Nov 2023 | 36,120 | 51,879 (0%) | 0% | 85 | 3,070,200 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.98 per share. | 21 Nov 2023 | 9,030 | 87,999 (0%) | 0% | 84.0 | 758,378 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 17 Oct 2023 | 9,030 | 60,909 (0%) | 0% | 43.0 | 388,109 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2023 | 9,030 | 63,456 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.49 per share. | 17 Oct 2023 | 7,054 | 52,179 (0%) | 0% | 82.5 | 581,851 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.53 per share. | 17 Oct 2023 | 1,676 | 59,233 (0%) | 0% | 81.5 | 136,642 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.89 per share. | 17 Oct 2023 | 300 | 51,879 (0%) | 0% | 82.9 | 24,866 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2023 | 18,060 | 72,486 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 12 Sep 2023 | 18,060 | 69,939 (0%) | 0% | 43.0 | 776,219 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.56 per share. | 12 Sep 2023 | 16,711 | 53,228 (0%) | 0% | 82.6 | 1,379,735 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.31 per share. | 12 Sep 2023 | 1,349 | 51,879 (0%) | 0% | 83.3 | 112,385 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 11 Jul 2023 | 27,090 | 51,879 (0%) | 0% | 90 | 2,438,100 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 11 Jul 2023 | 27,090 | 78,969 (0%) | 0% | 43.0 | 1,164,328 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 27,090 | 90,546 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 11 Jul 2023 | 18,060 | 69,939 (0%) | 0% | 43.0 | 776,219 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 87.83 per share. | 11 Jul 2023 | 18,060 | 51,879 (0%) | 0% | 87.8 | 1,586,295 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 18,060 | 117,636 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 84.83 per share. | 13 Jun 2023 | 27,090 | 51,879 (0%) | 0% | 84.8 | 2,298,085 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 27,090 | 135,696 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 13 Jun 2023 | 27,090 | 78,969 (0%) | 0% | 43.0 | 1,164,328 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.98 per share. | 16 May 2023 | 9,030 | 60,909 (0%) | 0% | 43.0 | 388,109 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2023 | 9,030 | 162,786 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.65 per share. | 16 May 2023 | 9,030 | 51,879 (0%) | 0% | 83.6 | 755,351 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 84.44 per share. | 11 Apr 2023 | 30,779 | 51,879 (0%) | 0% | 84.4 | 2,598,831 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2023 | 30,779 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 11 Apr 2023 | 30,779 | 82,658 (0%) | 0% | 45.5 | 1,400,445 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 14 Mar 2023 | 30,780 | 82,659 (0%) | 0% | 45.5 | 1,400,490 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 30,780 | 30,779 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.04 per share. | 14 Mar 2023 | 26,375 | 56,284 (0%) | 0% | 81.0 | 2,137,517 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 81.53 per share. | 14 Mar 2023 | 4,405 | 51,879 (0%) | 0% | 81.5 | 359,139 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2023 | 98,200 | 98,200 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Feb 2023 | 98,200 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 30,780 | 61,559 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.50 per share. | 13 Feb 2023 | 30,780 | 82,659 (0%) | 0% | 45.5 | 1,400,490 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.28 per share. | 13 Feb 2023 | 17,336 | 65,323 (0%) | 0% | 83.3 | 1,443,706 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 83.76 per share. | 13 Feb 2023 | 13,444 | 51,879 (0%) | 0% | 83.8 | 1,126,073 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 98,200 | 98,200 | - | - | Employee Stock Option (Right to Buy) | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 54,546 | 140,432 (0%) | 0% | 0 | Class A Common Stock | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 27,273 | 27,273 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 17,208 | 148,964 (0%) | 0% | - | Class A Common Stock | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 17,208 | 0 | - | - | Performance-Based Restricted Stock Unit | |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.07 per share. | 15 Dec 2022 | 13,800 | 129,807 (0%) | 0% | 71.1 | 980,766 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.17 per share. | 15 Dec 2022 | 10,756 | 85,886 (0%) | 0% | 73.2 | 787,017 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.80 per share. | 15 Dec 2022 | 5,082 | 119,557 (0%) | 0% | 70.8 | 359,806 | Class A Common Stock |
| Dolby Laboratories Inc | Kevin J. Yeaman | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2022 | 16,688 | 171,816 | - | - | Employee Stock Option (right to buy) |